Decreased Availability of Antimalarials in the Private Sector Following the Policy Change from Chloroquine to Sulphadoxine-Pyrimethamine in the Kilombero Valley, Tanzania

Simple item page
dc.contributor.authorHetzel, Manuel W.
dc.contributor.authorMsechu, June J.
dc.contributor.authorGoodman, Catherine
dc.contributor.authorLengeler, Christian
dc.contributor.authorObrist, Brigit
dc.contributor.authorKachur, Patrick S.
dc.contributor.authorMakemba, Ahmed
dc.contributor.authorNathan, Rose
dc.contributor.authorSchulze, Alexander
dc.contributor.authorMshinda, Hassan
dc.date.accessioned2016-07-09T20:32:36Z
dc.date.available2016-07-09T20:32:36Z
dc.date.issued2006
dc.description.abstractBackground: Malaria control strategies emphasize the need for prompt and effective treatment of malaria episodes. To increase treatment efficacy, Tanzania changed its first-line treatment from chloroquine to sulphadoxine-pyrimethamine (SP) in 2001. The effect of this policy change on the availability of antimalarials was studied in rural south-eastern Tanzania. Methods: In 2001 and 2004, the study area was searched for commercial outlets selling drugs and their stocks were recorded. Household information was obtained from the local Demographic Surveillance System. Results: From 2001 to 2004, the number of general shops stocking drugs increased by 15% and the number of drug stores nearly doubled. However, the proportion of general shops stocking antimalarials dropped markedly, resulting in an almost 50% decrease of antimalarial selling outlets. This led to more households being located farther from a treatment source. In 2004, five out of 25 studied villages with a total population of 13,506 (18%) had neither a health facility, nor a shop as source of malaria treatment. Conclusion: While the change to SP resulted in a higher treatment efficacy, it also led to a decreased antimalarial availability in the study area. Although there was no apparent impact on overall antimalarial use, the decline in access may have disproportionately affected the poorest and most remote groups. In view of the imminent policy change to artemisinin-based combination therapy these issues need to be addressed urgently if the benefits of this new class of antimalarials are to be extended to the whole population.en_US
dc.identifier.citationHetzel, M.W., Msechu, J.J., Goodman, C., Lengeler, C., Obrist, B., Kachur, S.P., Makemba, A., Nathan, R., Schulze, A. and Mshinda, H., 2006. Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malaria journal, 5(1), p.1.en_US
dc.identifier.doi10.1186/1475-2875-5-109
dc.identifier.urihttp://hdl.handle.net/20.500.11810/3024
dc.language.isoen_USen_US
dc.publisherBioMed Centralen_US
dc.titleDecreased Availability of Antimalarials in the Private Sector Following the Policy Change from Chloroquine to Sulphadoxine-Pyrimethamine in the Kilombero Valley, Tanzaniaen_US
dc.typeJournal Article, Peer Revieweden_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.pdf
Size:
2.39 MB
Format:
Adobe Portable Document Format
Description:
Full text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Department of Sociology and Anthropology